Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 3Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Breast 1

Conditions

Lymphoma 2HER2 Positive Breast Carcinoma 1

Interventions

Cyclophosphamide 640Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 454Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 372Dexamethasone 351Doxorubicin 328Nivolumab 308Fluorouracil 286Capecitabine 260Prednisone 244Etoposide 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 210fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Geriatric Assessment × Clear all
NCT02054741 2024-04-12

Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer

University of Rochester

Phase NA Completed
733 enrolled 27 charts
Lymphoid

Lymphoma

NCT02107443 2024-04-12

COACH

University of Rochester

Phase NA Completed
546 enrolled 15 charts
Lymphoid

Lymphoma

NCT02673398 2023-06-18

Neratinib in Treating Older Patients With Stage IV HER2-Positive Breast Cancer

City of Hope Medical Center

Phase 2 Completed
25 enrolled 18 charts
Breast

HER2 Positive Breast Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡